Locally Advanced Solid Neoplasm: Clinical Trials

2 trials for Locally Advanced Solid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Active not recruiting 1

Follow Locally Advanced Solid Neoplasm: new trials by email Literature Review of Locally Advanced Solid Neoplasm trials Research Report on Locally Advanced Solid Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies
Abexinostat, Pembrolizumab - Stage III Cutaneous Melanoma, Stage IV Cutaneous Melanoma
Phase 1CompletedRahul Aggarwal352018-08-202024-03-22
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
Laboratory Biomarker Analysis, Pembrolizumab - BRCA1 Gene Mutation, BRCA2 Gene Mutation
Phase 2Active not recruitingRutgers, The State University of New Jersey212018-03-082026-04-03

Narrower conditions

Neoplasm Metastasis (2)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Transitional Cell (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Ovarian Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Ureteral Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Neoplastic Processes (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin Diseases (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)

Interventions

pembrolizumab (2)  ·  abexinostat (1)

Sponsors

Rahul Aggarwal (1)  ·  Rutgers, The State University of New Jersey (1)

Countries

United States (2)

Top investigators

Eugenia Girda, MD (1)  ·  Rahul Aggarwal, MD (1)

NIH funding

P30CA072720 (1)